🕵️ LYRA Therapeutics, Inc. ($LYRA)
SEC insider & ownership activity, last 12 months · CIK 1327273 · every row links its SEC filing
Over the last 12 months insiders sold $535K with no open-market buying against it. Perceptive Advisors LLC sold $527K (Nov). 4 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Mar 13, 2026.
🚨 2 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $535K (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 0 | – | 12 | $527K | Nov 13, 2025 |
| Palasis Maria | 0 | – | 1 | $6K | Jan 6, 2026 |
| Cavalier Jason | 0 | – | 1 | $3K | Jan 6, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Sabby Management, LLC | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Hal Mintz | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 13G | Jan 20, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Palasis Maria | $3K | Jan 27, 2026 | filing ↗ |
| Palasis Maria | $6K | Jan 6, 2026 | filing ↗ |
| Palasis Maria | $4K | Oct 14, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Apr 13, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 31, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 13, 2026 | filing ↗ |
| Debt acceleration (2.04) | Feb 23, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 2, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Jan 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 9, 2026 | filing ↗ |
| Other events (8.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Other events (8.01) | Sep 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 20, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 1, 2025 | filing ↗ |